Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-19-046715

SVP & Chief Financial Officer sold 5,063 shares at $18.15 ($91,893)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Labrucherie Gil M SVP & Chief Financial Officer 2019-08-16 Sale −5,063 $18.15 $91,893 122,872 D
Open-market sales · 5,063 sh · avg $18.15 · $91,893
Loading xslF345X03/doc4.xml…